BridgeMD
New treatment option for Stimulant Use (Diagnosis)
Official title Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
ClinicalTrials.gov ID: NCT05702021
What this study is testing
- What it's testing
- Stimulants constitute a new and deadly fourth wave of the opioid epidemic. Contingency management is the most effective intervention for stimulant use and is an evidence-based adjunct to medication for opioid use disorder.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Opioid Treatment Program Counselors:
- 1) provide ongoing psychosocial support to medication for opioid use disorder patients (e.g., intake sessions, individual counseling, and/or group...
You likely can't join if
- Younger than 18 years of age, unable to provide informed consent
- Persons on Medication for Opioid Use Disorder [Not recruited, via electronic medical records only]
- Inclusion criteria: must be newly initiated on medication for opioid use disorders (within the past 30 days) and have concurrent stimulant use...
- Exclusion criteria: Younger than 18 years of age, Does not have electronic medical records
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
- Rockford, Illinois, United States
- Pawtucket, Rhode Island, United States
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States; Rockford, Illinois, United States; Pawtucket, Rhode Island, United States; Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.